KIMBERLEE WALSH: Open Payments
NPI 1831412659 · SANTA CRUZ, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,007 in 34 payments from 12 companies in 2025. Trend: 2023 $1,569 · 2024 $4,255 · 2025 $1,007
Food & beverage: $912Education: $95
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $255 |
| Amgen Inc. | 6 | $179 |
| Janssen Biotech, Inc. | 2 | $126 |
| UCB, Inc. | 3 | $86 |
| Mallinckrodt Hospital Products Inc. | 3 | $70 |
| ANI Pharmaceuticals, Inc. | 3 | $70 |
| Lilly USA, LLC | 2 | $62 |
| Aurinia Pharma U.S., Inc. | 2 | $56 |
| Novartis Pharmaceuticals Corporation | 2 | $41 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $26 |
Products named: EVENITY, TREMFYA, RINVOQ, Bimzelx, ACTHAR, PURIFIED CORTROPHIN GEL, TALTZ, LUPKYNIS.
Industry payments across CA — which companies pay providers there.
